US67576A1007
US67576A1007
Ocular Therapeutix, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 51.951.000 | 63.723.000 | 18.5% |
| Cost of Revenue | 6.574.000 | 5.626.000 | 16.9% |
| Gross Profit | 45.377.000 | 58.097.000 | 21.9% |
| 315.394.000 | 229.878.000 | 37.2% | |
| Operating Income | -270.017.000 | -171.781.000 | 57.2% |
| Pretax Income | -265.939.000 | -193.506.000 | 37.4% |
| Net Income Common Stockholders | -265.939.000 | -193.506.000 | 37.4% |
| -- | -- | -- | |
| -- | -- | -- |